Skip to main content

Amgen

Amgen is a publicly listed biotechnology company headquartered in the United States. It specialises in the discovery, development, manufacturing and delivery of human therapeutics across oncology, inflammation, general medicine and rare diseases. Its product portfolio includes well-known medicines such as Enbrel, Prolia and Repatha, and in 2023 it completed the acquisition of Horizon Therapeutics to strengthen its rare disease business. Amgen is ranked among the largest U.S. companies, and is included in the Fortune lists and Forbes Global 2000 list.

North America
Pharmaceuticals & Biotechnology
Public
Not Engaged
Visit Website
ACT Core
G Uncommitted
Just Transition
0.0/100
Nature Benchmark
14.9/100
Social Benchmark
13.9/100
Gender Assessment
24.9/100
On this page

Subscribe to stay informed on our work

Keep up to date with all the latest from World Benchmarking Alliance

Join our newsletter